Paragon Genomics

Paragon Genomics

Private
Fremont, CaliforniaHealthcare & Life Scienceshttps://www.paragongenomics.com

Last Round

Series A

Sep 12, 2017

Total Funding Raised

$8M

Company Overview

Paragon Genomics, Inc. is a life science company that develops and commercializes advanced target enrichment and library preparation solutions for Next-Generation Sequencing (NGS). The company's proprietary CleanPlex® technology utilizes a multiplex PCR-based method to enable rapid and cost-effective targeted sequencing. Its products are applied in various research and clinical fields, including precision oncology, infectious disease surveillance, inherited disease testing, and molecular breeding. Headquartered in Fremont, California, the company aims to simplify NGS workflows and improve the accuracy of genomic sequencing for researchers, testing labs, and biopharmaceutical projects.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Precision Medicine, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

target enrichmentNGS library prepamplicon sequencingcustom NGS panelsmultiplex PCRtargeted sequencingNext-Generation SequencingNGSprecision oncologyinfectious disease surveillancelibrary preparation kitsamplicon-seqinherited disease testingagrigenomicsliquid biopsygenomics toolsfusion detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Paragon Genomics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Paragon Genomics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ASep 12, 2017

Paragon Genomics Investors

Notable investors and investment history

InvestorRounds
Heda VenturesSeries A
Cloudstone Venture FundSeries A
Wisemont CapitalSeries A

Paragon Genomics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Paragon Genomics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Paragon Genomics's valuation, stock price, and market status.

Firmographic Details

HeadquartersFremont, California
Employee Range17
Year Founded2015
Last FundingSep 12, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.